trafficking of NK cells after infusion
Showing 1 - 25 of >10,000
Malignant Sarcoma Trial in Madrid (Natural Killer (NK) cells (a new immunotherapy))
Recruiting
- Malignant Sarcoma
- Natural Killer (NK) cells (a new immunotherapy)
-
Madrid, SpainHospital Universitario La Paz
Jul 19, 2023
Acute Myeloid Leukemia Trial in Xuzhou (allogenic NK cells)
Recruiting
- Acute Myeloid Leukemia
- allogenic NK cells
-
Xuzhou, Jiangsu, ChinaThe Affiliated Hospital of Xuzhou Medical University
Feb 23, 2023
Acute Myeloid Leukemia, MDS, Myeloproliferative Tumor Trial in Boston (CIML NK, Fludarabine, Cyclophosphamide)
Recruiting
- Acute Myeloid Leukemia
- +3 more
- CIML NK
- +2 more
-
Boston, Massachusetts
- +1 more
Jan 6, 2023
Acute Myeloid Leukemia in Children Trial in Saint Louis (CIML NK Cell Infusion, CD3+ T Cell Product Infusion)
Recruiting
- Acute Myeloid Leukemia in Children
- CIML NK Cell Infusion
- CD3+ T Cell Product Infusion
-
Saint Louis, MissouriWashington University School of Medicine
Oct 26, 2022
Colon Cancer Stage I Trial in Taoyuan (Magicell-NK contains NK cells suspended in 100 mL normal saline)
Recruiting
- Colon Cancer Stage I
- Magicell-NK contains NK cells suspended in 100 mL normal saline
-
Taoyuan, TaiwanChang Gung Memorial Hospital, Linkou
Sep 28, 2022
Hematologic Malignancy Trial in Chengdu (Allogeneic Hematopoietic Stem Cell Transplantation)
Recruiting
- Hematologic Malignancy
- Allogeneic Hematopoietic Stem Cell Transplantation
-
Chengdu, Sichuan, ChinaWest China Hospital of Sichuan University
Mar 12, 2022
Acute Myeloid Leukemia, Leukemia, Leukemia, Myeloid Trial in Boston (Cytokine Induced Memory-like Natural Killer Cells,
Not yet recruiting
- Acute Myeloid Leukemia
- +5 more
- Cytokine Induced Memory-like Natural Killer Cells
- Interleukin-2
-
Boston, Massachusetts
- +1 more
Nov 14, 2023
Advanced Melanoma, Metastatic Melanoma Trial in Saint Louis (Memory-like natural killer cells, Relatilmab, Nivolumab)
Not yet recruiting
- Advanced Melanoma
- Metastatic Melanoma
- Memory-like natural killer cells
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Nov 16, 2022
Acute Myeloid Leukemia Trial in Saint Louis (Graft cell infusion, Tacrolimus, Mycophenolate mofetil)
Recruiting
- Acute Myeloid Leukemia
- Graft cell infusion
- +6 more
-
Saint Louis, MissouriWashington University School of Medicine
Jan 29, 2023
Acute Myeloid Leukemia, Myelodysplasia Trial in Roma (Haplo SCT with NK cells, Haplo SCT)
Recruiting
- Acute Myeloid Leukemia
- Myelodysplasia
- Haplo SCT with NK cells
- Haplo SCT
-
Roma, RM, ItalyFondazione Policlinico Universitario A. Gemelli IRCCS
Oct 14, 2021
High-risk Leukemias Trial in Spain (NK cells stimulated ex vivo with IL-15, Alloreactive NK cells)
Recruiting
- High-risk Leukemias
- NK cells stimulated ex vivo with IL-15
- Alloreactive NK cells
-
Santiago De Compostela, A Coruña, Spain
- +9 more
Mar 30, 2022
ACUTE LEUKEMIA Trial in Madrid (Donor IL-15 stimulated NK cells infusion)
Completed
- ACUTE LEUKEMIA
- Donor IL-15 stimulated NK cells infusion
-
Madrid, SpainHospital General Universitario Gregorio Marañón
Sep 2, 2021
Ewing Sarcoma, Neuroblastoma, Rhabdomyosarcoma Trial in Milwaukee (Allogeneic HCT, Donor NK Cell Infusion)
Active, not recruiting
- Ewing Sarcoma
- +4 more
- Allogeneic HCT
- Donor NK Cell Infusion
-
Milwaukee, Wisconsin
- +1 more
Apr 5, 2022
Cytomegalovirus, Adenovirus Trial in Memphis (VST infusion, CliniMACS)
Not yet recruiting
- Cytomegalovirus
- Adenovirus
- VST infusion
- CliniMACS
-
Memphis, TennesseeSt . Jude Children's Research Hospital
Jan 9, 2023
Multiple Myeloma Trial in Madrid (NKAE cells infusion, Lenalidomide, Bortezomib)
Completed
- Multiple Myeloma
- NKAE cells infusion
- +2 more
-
Madrid, SpainHospital Universitario 12 de Octubre
Aug 19, 2021
Adult Acute Myeloid Leukemia in Remission Trial in Bologna (Alloreactive NK cell infusion)
Recruiting
- Adult Acute Myeloid Leukemia in Remission
- Alloreactive NK cell infusion
-
Bologna, BO, ItalyAntonio Curti
Jan 18, 2021
Haematological Malignancies Trial in London, Manchester (CD25/71 allodepleted donor T-cells)
Completed
- Haematological Malignancies
- CD25/71 allodepleted donor T-cells
-
London, United Kingdom
- +1 more
Jul 18, 2022
Cord Trial in Jinan (Intravenous infusion of cord blood mononuclear cells, application of granulocyte stimulating factor)
Recruiting
- Cord
- Intravenous infusion of cord blood mononuclear cells
- application of granulocyte stimulating factor
-
Jinan, Shandong, ChinaPediatrics, Qianfoshan Hospital
Nov 25, 2022
Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, Relapsed, Adult Trial in Nijmegen (UCB-NK cells, IL-2)
Recruiting
- Acute Myeloid Leukemia Refractory
- Acute Myeloid Leukemia, Relapsed, Adult
- UCB-NK cells
- IL-2
-
Nijmegen, NetherlandsRadboud University Medical Center
Nov 10, 2021
Relapsed Hematologic Malignancy Trial in Bergamo (donor-derived CIK cells)
Recruiting
- Relapsed Hematologic Malignancy
- donor-derived CIK cells
-
Bergamo, ItalyA O Papa Giovanni XXIII
Dec 22, 2021
CMV Viremia, Transplantation Infection Trial in Beijing (expanded NK cells)
Recruiting
- CMV Viremia
- Transplantation Infection
- expanded NK cells
-
Beijing, Beijing, ChinaPeking University Institute of Hematology
Jun 10, 2021
Hematologic Malignancy Trial in Pavia, Rome, Turin (BPX-501 T cells, rimiducid)
Active, not recruiting
- Hematologic Malignancy
- BPX-501 T cells
- rimiducid
-
Pavia, Italy
- +2 more
Jul 10, 2022
Allogeneic Stem Cell Transplant, Viral Infection, Viral Reactivation Trial in Cincinnati (Viral specific VST Infusion)
Recruiting
- Allogeneic Stem Cell Transplant
- +2 more
- Viral specific VST Infusion
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Aug 15, 2022
Refractory Metastatic Colorectal Cancer Trial in Guangzhou (CAR-T infusion)
Recruiting
- Refractory Metastatic Colorectal Cancer
- CAR-T infusion
-
Guangzhou, Guangdong, ChinaThe Third Affiliated Hospital of Guangzhou Medical University
Feb 9, 2022